Related Questions

কোন হরমনের অভাবে ‘ Diabetes Mellitus ' হয়?
A গ্লুকান
B ইনসুলিন
C কটিসল
D ইস্ট্রোজেন
নিচের কোন হরমোনের অভাবে Diabetes mellitus হয়?
A গ্লুকাগন
B কর্টিসল
C ইনসুলিন
D ইস্ট্রোজেন
Diagnostic criteria for diabetes mellitus are
A HbA1C≥6.5%
B 2-hour plasma glucose ≥11.1 mmol/L during oral glucose tolerance test
C Fasting plasma glucose ≥ 7.8 mmol/L
D Presence of glucose in the urine
E Presence of ketone bodies in the urine
Type 1 diabetes mellitus
A Shows seasonal incidence
B Always requires insulin
C Has strong familial predisposition
D Is characterized by insulin resistance
E Shows high level of C- peptide
In management of diabetes mellitus
A Structured education program is mandatory
B Many oral hypoglycemic agents cause weight gain
C Basal bolus insulin regime has less chance of hypoglycemia [Davidson’s/750]
D Metformin impairs renal functions
E Incretin drugs cannot be combined with other oral drugs
Gestational diabetes mellitus are associated with
A Intra uterine growth retardation
B Big baby
C Pre eclampsia
D Hyperemesis gravidarum
E Polyhydramnios
Skin manifestations in diabetes mellitus are
A Necrobiosis lipoidica
B Shin spot
C Xerosis
D Spider angioma
E Hypertrichosis
The following statements about Pharmacotherapy of Diabetes Mellitus are correct
A Insulin therapy is always associated with some degree of hypoglycaemia
B Resistance against human insulin is best treated by changing to bovine insulin
C Pregnant diabetic patients are best treated by Biguanides because they are not teratogenic
D Human insulin is best therapeutically because of lesser chance of hypoglycaemia
E α-glucosidase inhibitor therapy is equally effective as Sulphonylurea drug in NIDDM
Secondary diabetes mellitus is associated with
A Haemochromatosis
B Acromegaly
C Pancreatic carcinoma
D Frusemide
E Hypothyroidsm
In patients with diabetes mellitus
A Blood pressure control target should be lower than that of non diabetic
B Lipid control target should be lower than that of non-diabetic
C Periodic fundoscopic examination reduces eye complications
D Angiotensin converting enzyme inhibitor do not prevent progression of nephropathy
E Good glycaemic control do not prevent major diabetic complication

Next steps